ID16921A - Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 - Google Patents

Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Info

Publication number
ID16921A
ID16921A IDP971640A ID971640A ID16921A ID 16921 A ID16921 A ID 16921A ID P971640 A IDP971640 A ID P971640A ID 971640 A ID971640 A ID 971640A ID 16921 A ID16921 A ID 16921A
Authority
ID
Indonesia
Prior art keywords
cycloxigenase
composition
diseases related
against diseases
day treatment
Prior art date
Application number
IDP971640A
Other languages
English (en)
Indonesian (id)
Inventor
Bruno Hancock
Conrad Winters
Barry Gertz
Elliot Ehrich
Original Assignee
Merck & Co Inc
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309472&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16921(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612063.9A external-priority patent/GB9612063D0/en
Application filed by Merck & Co Inc, Merck Frosst Canada Inc filed Critical Merck & Co Inc
Publication of ID16921A publication Critical patent/ID16921A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP971640A 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 ID16921A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1787896P 1996-05-17 1996-05-17
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (1)

Publication Number Publication Date
ID16921A true ID16921A (id) 1997-11-20

Family

ID=26309472

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971640A ID16921A (id) 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Country Status (29)

Country Link
US (1) US6063811A (is)
EP (1) EP0910368A1 (is)
JP (1) JPH11512754A (is)
KR (1) KR100373622B1 (is)
CN (1) CN1140267C (is)
AR (1) AR012014A1 (is)
AU (1) AU3004997A (is)
BG (1) BG103000A (is)
BR (1) BR9709097A (is)
CA (1) CA2254061C (is)
CO (1) CO5050370A1 (is)
CZ (1) CZ291463B6 (is)
DZ (1) DZ2200A1 (is)
EA (1) EA001596B1 (is)
EE (1) EE03746B1 (is)
HK (1) HK1021623A1 (is)
HR (1) HRP970262A2 (is)
HU (1) HUP9902889A3 (is)
ID (1) ID16921A (is)
IL (1) IL126899A (is)
IS (1) IS4891A (is)
MY (1) MY116201A (is)
NO (1) NO985342L (is)
NZ (1) NZ332670A (is)
PE (1) PE66998A1 (is)
PL (1) PL188649B1 (is)
SK (1) SK284330B6 (is)
TR (1) TR199802345T2 (is)
WO (1) WO1997044028A1 (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
JP2002506024A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
EP1239856A1 (en) * 1999-12-22 2002-09-18 Pharmacia Corporation Sustained-release formulation of a cyclooxygenase-2 inhibitor
WO2001095898A1 (en) 2000-06-13 2001-12-20 Wyeth Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
NZ524124A (en) * 2000-08-18 2004-09-24 Pharmacia Corp Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
WO2002089798A2 (en) * 2001-05-04 2002-11-14 Merck & Co., Inc. Method and compositions for treating migraines
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition
KR20040058189A (ko) * 2001-09-26 2004-07-03 파마시아 코포레이션 관능상 허용가능한 경구내 붕해 조성물
OA12666A (en) * 2001-10-10 2006-06-19 Pharmacia Corp Corporate Paten Intraorally disintegrating valdecoxib compositionsprepared by spray drying process.
EP1492520A1 (en) * 2002-03-07 2005-01-05 Novartis AG Pharmaceutical compositions
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
EP1534305B9 (en) 2003-05-07 2007-03-07 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
US20100111858A1 (en) * 2007-01-19 2010-05-06 Howard Carol P Diangostic and Therapeutic Cyclooxygenase-2 Binding Ligands
CA3119728A1 (en) 2018-11-21 2020-05-28 Tremeau Pharmaceuticals, Inc. Purified forms of rofecoxib, methods of manufacture and use
US20200323813A1 (en) * 2019-04-09 2020-10-15 Tremeau Pharmaceuticals, Inc. Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal anti-inflammatory drugs
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
JP2788677B2 (ja) * 1994-01-10 1998-08-20 メルク フロスト カナダ インコーポレーテツド Ｃｏｘ−２阻害剤としてのフェニル複素環

Also Published As

Publication number Publication date
CA2254061C (en) 2003-12-02
CN1140267C (zh) 2004-03-03
IL126899A (en) 2004-03-28
NO985342D0 (no) 1998-11-16
JPH11512754A (ja) 1999-11-02
HRP970262A2 (en) 1998-06-30
WO1997044028A1 (en) 1997-11-27
BR9709097A (pt) 1999-08-03
NZ332670A (en) 2000-07-28
IL126899A0 (en) 1999-09-22
HUP9902889A2 (hu) 2002-01-28
KR100373622B1 (ko) 2003-07-12
EA001596B1 (ru) 2001-06-25
BG103000A (en) 1999-09-30
AU3004997A (en) 1997-12-09
CO5050370A1 (es) 2001-06-27
US6063811A (en) 2000-05-16
AR012014A1 (es) 2000-09-27
HK1021623A1 (en) 2000-06-23
CZ373898A3 (cs) 1999-06-16
IS4891A (is) 1998-11-10
PL188649B1 (pl) 2005-03-31
PE66998A1 (es) 1998-10-24
CA2254061A1 (en) 1997-11-27
EA199801017A1 (ru) 1999-04-29
PL329940A1 (en) 1999-04-26
MY116201A (en) 2003-11-28
EE03746B1 (et) 2002-06-17
DZ2200A1 (fr) 2004-06-20
SK156798A3 (en) 2000-01-18
HUP9902889A3 (en) 2002-04-29
CZ291463B6 (cs) 2003-03-12
EE9800393A (et) 1999-06-15
KR20000011082A (ko) 2000-02-25
TR199802345T2 (xx) 1999-03-22
NO985342L (no) 1998-11-16
CN1225010A (zh) 1999-08-04
EP0910368A1 (en) 1999-04-28
SK284330B6 (sk) 2005-01-03

Similar Documents

Publication Publication Date Title
ID16921A (id) Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2
DK0769017T3 (da) Terapeutiske forbindelser
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
DE69618854D1 (de) Fotopolymerisierbare Zusammensetzung
ID18168A (id) Mekanisma pengatur waktu katup bervariasi mesin
DE69520639D1 (de) Desinfizierende Zusammensetzung
BR9605176A (pt) Composição fotocurável
DE69626993T2 (de) Wundbehandlungszusammensetzung
DE69521039D1 (de) Gewebeweichmacherzusammensetzung
BR9607925A (pt) Composição fungicida
DE69604601D1 (de) Fotopolymerisierbare Zusammensetzung
DE69503738D1 (de) Fotopolymerisierbare Zusammensetzung
DE69505358D1 (de) Gewebeweichmacherzusammensetzung
ID17723A (id) Senyawa untuk pengobatan
EP0944635A4 (en) THERAPEUTIC DIPHOSPHONATE COMPOUNDS
NO983090D0 (no) Terapeutiske forbindelser
FI971447A0 (fi) Venttiili käsienpesuallasta varten
BR9607487A (pt) Composição herbicida
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
BR9503633A (pt) Composição desinfetante
BR9610382A (pt) Composição de tratamento do cableo
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons
DE69508069D1 (de) Gewebeweichnacherzusammensetzung
DE69605584D1 (de) Fotopolymerisierbare Zusammensetzung
FI972383A (fi) Osteoporoosihoitojaksoon tarkoitettu pakkaus